Enlight Medical 应脉医疗
Gilbert Hao is an accomplished medical professional and business leader, currently serving as Chief Medical Officer and Business Development Head at Enlight Medical since October 2020. Prior experience includes roles as Vice President and Investment Manager at CD Capital from April 2018 to September 2020, and as a Senior Investment Manager at Fosun Group between January 2017 and March 2018. Gilbert started a clinical career as a Resident and Attending Physician at Renji Hospital, affiliated with Shanghai Jiao Tong University, from October 2014 to December 2016, following an internship at the same institution from January 2009 to May 2010. Educational qualifications encompass a Doctor of Medicine (MD) from Shanghai Jiao Tong University and a Doctor of Philosophy (PhD) in Cardiology from Nagoya University, along with ongoing Executive MBA studies at China Europe International Business School since November 2022.
This person is not in any teams
Enlight Medical 应脉医疗
Enlight Medical Technologies (Shanghai) Co., Ltd. is committed to the product development, production, and distribution of innovative medical diagnostics and therapeutic devices. The founding team of the company has successful experience and industry resources in R&D, sales, and marketing. The R&D team is composed of senior engineers graduated from top universities in both China and the United States. The company's product pipeline has a wide layout, covering a variety of innovative products with huge market potential. The company will always take an international vision, uphold the heart of benevolence, based in China, to create a world-class technology provider and product manufacturer of innovative medical devices.